When Should You Get a First Mammogram? It’s Personal

Varying guidelines can make scheduling your first mammogram confusing. Talking with your doctor — and knowing your health history — can help.

7:00 AM

Author | Kevin Joy

When should a woman get her first mammogram?

It depends whom you ask.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

The age when average-risk patients are advised to start screening varies by the advisory group issuing the recommendation. So, too, does the exam's frequency.

In 2015, the American Cancer Society revised its guidelines to begin annual mammograms when a woman turns 45 — with the option to start at age 40, the society's previous threshold, if she wishes.

The National Comprehensive Cancer Network, an alliance of major cancer centers, says the test should be performed every year beginning at 40. On the other hand, the U.S. Preventive Services Task Force since 2009 has advised women 50 and older to receive biennial mammograms.

And in June, the American College of Obstetricians and Gynecologists changed its recommendations for average-risk women: Starting at 40, those patients should talk with their doctors about screening and, after a shared discussion, have the option to proceed.

The association previously advised that all women 40 and older receive annual mammograms. Now, it notes, a woman who doesn't initiate in her 40s should begin mammography by age 50.

Such shifts often make headlines. They might also leave patients confused.

Taken at face value, "these are very nuanced statistical arguments, and I think they have created a lot of uncertainty," says Mark Helvie, M.D., a professor of radiology at the University of Michigan Medical School and the director of Michigan Medicine's Division of Breast Imaging.

"But there's no ambiguity about the need for screening. The important thing is that all organizations recommend it."

What gets lost in the news coverage and conversation, notes Helvie, is that a patient and her doctor ultimately make the judgment call on when — and how often — to proceed.

"In the end," he says, "it's a woman's decision."

Starting the conversation

Breast cancer is the most common cancer in women and the second-leading cause of cancer death, according to the Centers for Disease Control and Prevention.

Mammograms, which are X-rays used to detect early signs of breast cancer, are a crucial tool.

SEE ALSO: What Women Should Know About Breast Density

Several key factors should guide a discussion of when to first carry out the test.

Among them: whether a woman has a strong family history of breast cancer without a known genetic predisposition. A breast cancer diagnosis in a first-degree relative on a woman's side nearly doubles her own risk.

Another issue is the presence of BRCA1 or BRCA2, gene mutations linked to an increased breast cancer risk — a detail that can be confirmed via genetic testing, a blood test that uses DNA analysis to check for possible mutations. MRI screening is recommended as early as age 25 among these women.

Women with dense breasts, which are marked by greater amounts of fibrous and glandular tissue than fat, have a higher risk of breast cancer. That density also makes mammograms less effective; supplemental tests such as MRI or ultrasound may be used to screen for cancer.

A history of obesity, heavy drinking or a sedentary lifestyle can contribute to developing breast cancer. So can using birth control.

Meanwhile, the American Cancer Society now distinguishes its mammography guidelines based on "strong" and "qualified" recommendations — in other words, whether performing the test outweighs any negative effects or offers benefits but less certainty about related harm, respectively.

Says Helvie: "It's the same nuance that has existed for a long time; they've just formalized it."

Risks and reward

Helvie, who sits on the guidelines panel for the National Comprehensive Cancer Network, says that doctors get two common questions about breast cancer screening.

Patients, naturally, want to know how the various group recommendations differ — and whether they need a mammogram annually or every other year.

SEE ALSO: Why You Need to Discuss Your Family Health History at Thanksgiving

Even if a woman's risk factor is low, Helvie notes that early action has benefits.

"Statistical models of screening show there's a 72 percent improvement in life years gained when a woman begins mammograms annually at 40," Helvie says, citing research on the subject he co-authored this year in the journal Cancer. "We think that's a substantial reason you want to be screened early."

Yearly screenings, he adds, increase a patient's life years gained by 25 percent compared with those who receive a mammogram biennially.

"Many physicians are unaware of that magnitude of difference," Helvie says.

Early screening does bear some risk, however — namely, the chance of false positive results that could lead to unnecessary biopsies, tests and treatment for women who don't have breast cancer (or whose cancers won't grow or cause problems otherwise).

Roughly half the women screened over 10 years will receive a false positive finding, according to the American Cancer Society. The vast majority of false positives are for extra mammogram views or ultrasound, which will prove negative. Patients and practitioners must acknowledge that potential outcome.

Still, maintains Helvie, "screening early and annually saves the most lives."


More Articles About: Cancer Care Breast cancer Mammography Health Care Delivery, Policy and Economics Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories out the window woman staring
Health Lab
1 in 3 older adults still experience loneliness and isolation
Rates of loneliness and social isolation in older people have declined from pandemic highs, but are still a problem especially for those with mental or physical health issues or disabilities.
patient looking at paper with provider in scrubs blue in clinic
Health Lab
How race impacts patients’ response to cancer immunotherapy
The first large scale analysis finds immune checkpoint inhibitors are equally effective in Black and white patients, with Black patients having fewer side effects.
bone close up of cells inside green bbble with cells inside in yellow brown pink and red orange background
Health Lab
How breast cancer cells survive in bone marrow after remission
A new study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.
three friends standing outside rogel cancer center building with big white ribbons
Health Lab
A lung cancer survivor shaping lung cancer advocacy
One woman's unexpected lung cancer diagnosis leads her to help many who aren't aware they're at risk of the disease.
On left, a young boy in a wheelchair has his doctor standing to his left and his parent is standing to his right in a show of support. On the right side of the image, the boy is now an adult and is wondering about the cost of his care and if his questions will be answered.
Health Lab
Changing the definition of cerebral palsy
Cerebral palsy is defined as a childhood disorder, which fails to recognize adults living with the condition and the lack of care they receive once they age out of pediatric clinics.
floating AI-type images in red and blues and yellow on blue background
Health Lab
Racial differences in medical testing could introduce bias to AI models
Black patients are less likely than white patients to receive certain medical tests that doctors use to diagnose severe disease, impacting artificial intelligence data. But researchers have found a way to correct the bias in these data sets.